Krystal Biotech, Inc. (KRYS)
Company Info
Highlights
$5.38B
$1.78
105.18
$241.52M
$218.55M
$70.06M
$96.73 - $219.34
$207.78
15.83%
23.12
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Krystal Biotech, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Krystal Biotech, Inc. had a return of 39.43% year-to-date (YTD) and 66.07% in the last 12 months.
KRYS
39.43%
-3.47%
5.41%
66.07%
26.32%
N/A
^GSPC (Benchmark)
23.62%
0.54%
11.19%
30.63%
13.61%
11.16%
Monthly Returns
The table below presents the monthly returns of KRYS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -10.33% | 43.34% | 11.58% | -13.94% | 4.53% | 14.74% | 13.52% | -6.40% | -6.71% | -5.22% | 39.43% | ||
| 2023 | 4.92% | -1.46% | -2.26% | 4.92% | 40.30% | -0.38% | 9.97% | -3.58% | -6.81% | 0.75% | -10.82% | 19.03% | 56.60% |
| 2022 | -15.65% | 7.71% | 4.70% | -8.91% | -2.85% | 11.51% | 10.54% | -3.40% | -0.58% | 9.76% | 1.62% | 1.90% | 13.25% |
| 2021 | 16.17% | 13.19% | -2.35% | 3.12% | -17.88% | 4.23% | -14.06% | -0.86% | -9.89% | -4.06% | 60.81% | -13.16% | 16.58% |
| 2020 | -5.63% | 2.28% | -19.10% | 9.14% | 8.94% | -19.43% | -0.31% | 15.79% | -9.96% | -0.14% | 27.80% | 9.21% | 8.34% |
| 2019 | 11.26% | -3.29% | 47.14% | -0.46% | -4.06% | 28.17% | 19.22% | -6.27% | -22.83% | 18.27% | 37.59% | -2.00% | 166.51% |
| 2018 | -5.13% | 1.00% | 0.10% | -4.76% | 7.08% | 44.51% | 10.63% | -0.06% | 6.93% | 17.24% | 23.14% | -18.12% | 97.53% |
| 2017 | -6.30% | -0.70% | 6.06% | 0.19% | -1.13% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current risk-adjusted rank of KRYS is 85, placing it in the top 15% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Krystal Biotech, Inc. (KRYS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Krystal Biotech, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Krystal Biotech, Inc. was 53.42%, occurring on Nov 26, 2021. Recovery took 1 trading session.
The current Krystal Biotech, Inc. drawdown is 19.04%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -53.42% | Mar 2, 2021 | 189 | Nov 26, 2021 | 1 | Nov 29, 2021 | 190 |
| -46.65% | Feb 13, 2020 | 24 | Mar 18, 2020 | 205 | Jan 8, 2021 | 229 |
| -44.55% | Nov 30, 2021 | 113 | May 11, 2022 | 231 | Apr 13, 2023 | 344 |
| -35.34% | Jul 23, 2019 | 50 | Oct 1, 2019 | 31 | Nov 13, 2019 | 81 |
| -28.43% | Sep 12, 2018 | 21 | Oct 10, 2018 | 4 | Oct 16, 2018 | 25 |
Volatility
Volatility Chart
The current Krystal Biotech, Inc. volatility is 13.26%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Krystal Biotech, Inc..
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |